Lung Screening in People Cured of Hodgkin Lymphoma

NCT04986189 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2024-11-04

No results posted yet for this study

Summary

A single site non-commercial study in which people treated for Hodgkin lymphoma survivors will be invited to have a single low dose CT of thorax for lung cancer screening

Conditions

Interventions

DIAGNOSTIC_TEST

Low dose CT thorax

A low dose CT scan of the thorax to screen for lung cancer

Sponsors & Collaborators

  • University of Manchester

    collaborator OTHER
  • The Christie NHS Foundation Trust

    lead OTHER

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2024-08-31
Completion
2024-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04986189 on ClinicalTrials.gov